Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.

MLA

Shiozawa, Kazue, et al. “Evaluation of Sorafenib for Hepatocellular Carcinoma by Contrast-Enhanced Ultrasonography: A Pilot Study.” World Journal of Gastroenterology, vol. 18, no. 40, Oct. 2012, pp. 5753–58. EBSCOhost, https://doi.org/10.3748/wjg.v18.i40.5753.

APA

Shiozawa, K., Watanabe, M., Kikuchi, Y., Kudo, T., Maruyama, K., & Sumino, Y. (2012). Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study. World Journal of Gastroenterology, 18(40), 5753–5758. https://doi.org/10.3748/wjg.v18.i40.5753

Chicago

Shiozawa, Kazue, Manabu Watanabe, Yoshinori Kikuchi, Takahide Kudo, Kenichi Maruyama, and Yasukiyo Sumino. 2012. “Evaluation of Sorafenib for Hepatocellular Carcinoma by Contrast-Enhanced Ultrasonography: A Pilot Study.” World Journal of Gastroenterology 18 (40): 5753–58. doi:10.3748/wjg.v18.i40.5753.